Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1

Immune checkpoint inhibition is an important strategy in cancer therapy. Blockade of CTLA-4 and PD-1/PD-L1 is well developed in clinical practice. In the last few years, LAG-3 has received much interest as an emerging novel target in immunotherapy. It was recently reported that FGL1 is a major ligan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wan-ting, Liu, Ting-ting, Wu, Man, Chen, Xiao-chen, Han, Li, Shi, Zhen-zhong, Li, Yu-ying, Li, Xi-yang, Xu, Hai-xing, Gong, Li-kun, Xu, Pei-hu, Geng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563870/
https://www.ncbi.nlm.nih.gov/pubmed/33633363
http://dx.doi.org/10.1038/s41401-020-00574-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563870/
https://www.ncbi.nlm.nih.gov/pubmed/33633363
http://dx.doi.org/10.1038/s41401-020-00574-4

Ejemplares similares